Aiseon is creating a Artificial Intelligence platform backed with Machine Learning and Deep Learning algorithms to diagnose assisted Diabetic Retinopathy and reach out to masses in India. Our aim is to bridge the gap between the ophthalmologist and their inability to reach to the rural areas of India. Our Platform will be able to detect Diabetic Retinopathy or no Diabetic Retinopathy in just minutes, which shall be a time saver for the doctors in screening and help them attain further treatment / surgery related issues.

Other business activities

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.